These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 901673

  • 1. Beta blockade in essential hypertension: an analysis of response to oxprenolol.
    Barritt DW, Marshall AJ.
    Br Heart J; 1977 Aug; 39(8):825-8. PubMed ID: 901673
    [Abstract] [Full Text] [Related]

  • 2. Comparison of oxprenolol and methyldopa in hypertension. A within-patient double-blind trial.
    Barritt DW, Marshall AJ, Heaton S.
    Lancet; 1976 Mar 06; 1(7958):503-5. PubMed ID: 55780
    [Abstract] [Full Text] [Related]

  • 3. The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension.
    Millar-Craig MW, Mann S, Bala Subramanian V, Altman DG, Raftery EB.
    Eur J Clin Pharmacol; 1983 Mar 06; 24(6):713-21. PubMed ID: 6884408
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of two oxprenolol oral osmotic (OROS) delivery systems in patients with essential hypertension.
    McInnes GT, Brodie MJ.
    Eur J Clin Pharmacol; 1988 Mar 06; 34(6):605-11. PubMed ID: 3169112
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hemodynamic effects of oxprenolol and propranolol in hypertension.
    Franciosa JA, Johnson SM, Tobian LJ.
    Clin Pharmacol Ther; 1979 Dec 06; 26(6):676-81. PubMed ID: 387330
    [Abstract] [Full Text] [Related]

  • 9. Comparative anti-hypertensive effects of labetalol and the combination of oxprenolol and phentolamine.
    Johnson BF, LaBrooy J, Munro-Faure AD.
    Br J Clin Pharmacol; 1976 Aug 06; 3(4 Suppl 3):783-7. PubMed ID: 791332
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.
    Motolese M, Muiesan G, Colombi A.
    Eur J Clin Pharmacol; 1975 Aug 06; 8(1):21-31. PubMed ID: 786673
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparison of slow release oxprenolol with conventional oxprenolol in the treatment of hypertension.
    Resnekov EB, Havard CW.
    Eur J Clin Pharmacol; 1978 Nov 16; 14(2):77-81. PubMed ID: 363434
    [Abstract] [Full Text] [Related]

  • 14. Treatment of hypertension with large doses of the beta-adrenergic blocking drug oxprenolol, alone, and in combination with the vasodilator dihydralazine.
    Tuckman J, Messerli F, Hodler J.
    Clin Sci Mol Med Suppl; 1973 Aug 16; 45 Suppl 1():159s-61. PubMed ID: 4593561
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interference by sulphinpyrazone with the antihypertensive effects of oxprenolol.
    Ferrara LA, Mancini M, Marotta T, Pasanisi F, Fasano ML.
    Eur J Clin Pharmacol; 1986 Aug 16; 29(6):717-9. PubMed ID: 3519237
    [Abstract] [Full Text] [Related]

  • 17. The acute and chronic effects of oxprenolol on ambulatory blood pressure and heart rate in essential hypertension [proceedings].
    Millar-Craig MW, Mann S, Balasubramanian V, Altman D, Raftery EB.
    Br J Clin Pharmacol; 1979 Oct 16; 8(4):389P. PubMed ID: 508527
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Beta adrenergic blockade and diuretic therapy in benign essential hypertension: A dynamic assessment.
    Davies R, Payne NN, Slater JD.
    Am J Cardiol; 1976 Mar 31; 37(4):637-41. PubMed ID: 3963
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.